A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/1999
12/16/1999	CA2321273A1 Novel analgesic agents
12/16/1999	CA2321190A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999	CA2321170A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999	CA2321166A1 Multibinding inhibitors of topoisomerase
12/16/1999	CA2321162A1 Novel antibacterial compounds
12/16/1999	CA2321152A1 Novel therapeutic agents that modulate endothelin receptors
12/16/1999	CA2321120A1 .beta.3-adrenergic receptor agonists
12/16/1999	CA2320926A1 Novel leukotriene receptor antagonists and their uses
12/16/1999	CA2320290A1 Multibinding inhibitors of cyclooxygenase-2
12/16/1999	CA2320241A1 Multivalent macrolide antibiotics
12/16/1999	CA2319756A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999	CA2319751A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999	CA2319730A1 Bradykinin antagonists
12/16/1999	CA2319651A1 H1-histamine receptor antagonists
12/16/1999	CA2319643A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999	CA2319497A1 Novel therapeutic agents that modulate estrogen receptors
12/16/1999	CA2319496A1 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999	CA2319495A1 Multibinding inhibitors of microsomal triglyceride transferase protein
12/16/1999	CA2319477A1 Inhibitors of h+k+-atpase
12/16/1999	CA2319474A1 Inhibitors of nitric oxide synthase
12/16/1999	CA2319175A1 Multibinding agents that modulate nmda receptors
12/16/1999	CA2319159A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999	CA2319153A1 Novel sodium channel drugs and uses
12/16/1999	CA2319142A1 Novel therapeutic agents for membrane transporters
12/16/1999	CA2319120A1 Phosphodiesterase-v modulator drugs and their uses
12/16/1999	CA2319068A1 Novel angiotensin receptor modulators and their uses
12/16/1999	CA2318901A1 Novel calcium channel drugs and uses
12/16/1999	CA2318894A1 .beta.2-adrenergic receptor agonists
12/16/1999	CA2318806A1 Multibinding agents that modulate the 5-ht transporter
12/16/1999	CA2318745A1 Novel potassium channel drugs and their uses
12/16/1999	CA2318286A1 Multibinding agents that modulate ppar.gamma. and rxr receptors
12/16/1999	CA2318055A1 .beta.2-adrenergic receptor agonists
12/16/1999	CA2316999A1 Inhibitors of hiv reverse transcriptase
12/16/1999	CA2315883A1 Muscarinic receptor antagonists
12/16/1999	CA2293694A1 New carboxypeptidase inhibitor
12/15/1999	EP0963987A2 Spiro(piperidine-4,1'-pyrrolo(3,4-c)pyrrole)
12/15/1999	EP0963985A2 Di-or triaza-spiro(4,5)decane derivatives
12/15/1999	EP0963983A1 Indol-2-ones as serotonin modulators
12/15/1999	EP0963981A1 Biaryl heterocyclic aromatic compounds, pharmaceutical and cosmetic compositions containing them and uses thereof
12/15/1999	EP0963757A2 Hemostatic agent
12/15/1999	EP0963756A2 Inhibition of LDL oxidation and atherosclerosis
12/15/1999	EP0963372A1 5-aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists
12/15/1999	EP0963371A1 Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase
12/15/1999	EP0963205A1 T1 receptor-like ligand ii
12/15/1999	EP0963203A2 Mammalian tolloid-like gene and protein
12/15/1999	EP0765305B1 Anti-inflammatory compounds
12/15/1999	EP0743949B1 Process for producing endotoxin-free or endotoxin-poor nucleic acids and/or oligonucleotides for gene therapy
12/15/1999	EP0725782B1 A 1 adenosine receptor agonists and antiagonists
12/15/1999	EP0664703B1 Methods of combating (pneumocystis carinii) pneumonia and compounds useful therefor
12/15/1999	EP0658110B1 Use of norastemizole for the treatment of allergic rhinitis
12/15/1999	EP0646008B1 Minimizing progestin associated breakthrough bleeding
12/15/1999	EP0584283B1 Osteoinductive protein mixtures and purification processes
12/15/1999	CN1238807A Stabilized transient gene expression
12/15/1999	CN1238770A Tricyclic antitumor compounds being farnesyl protein transferase inhibitors
12/15/1999	CN1238764A ApoB-secretion/MTP inhibitory amides
12/15/1999	CN1238761A Benzamidoaldehydes and their use as cryteine protease inhibitors
12/15/1999	CN1238702A Radiolabeled DNA oligonuleotide, method of preparation and therapeutic uses
12/15/1999	CN1238689A Vitronectin receptor antagonists
12/15/1999	CN1238207A Tonic liquid of black ewe's placenta extract and its preparing method
12/15/1999	CN1238186A Medicine for curing hemiplegia and its preparing process
12/15/1999	CN1047385C 3-indolylpiperidine and medinal composition containing them
12/14/1999	US6002014 Selectively inhibiting the action of cox-2; treating inflammation
12/14/1999	US6001972 Splicing variant of the epstein-barr virus-induced G-protein coupled receptor
12/14/1999	US6001970 Modified human neuropeptide Y1 Receptors
12/14/1999	US6001961 Cyclic adhesion inhibitors
12/14/1999	US6001885 Retinoid inhibition of expression of VEGF
12/14/1999	US6001882 Photoactivated hypericin and the use thereof
12/14/1999	US6001881 Administering to treat arrhythmia, angina pectoris, ischemia, shock, cell proliferation, fibrotic diseases, prostate hyperplasia, fat metabolism disorders, and as a preservative for transplant organs, or to prepare a patient for surgery
12/14/1999	US6001856 β-adrenergic agonists to reduce a wasting condition
12/14/1999	US6001855 Thiazole derivatives
12/14/1999	US6001839 Substituted 4-amino-7H-pyrrolo [2,3,-d]-pyrimidines as PTK inhibitors
12/14/1999	US6001833 Novel piperazine derivatives which are substituted in the 2-position by an indolylmethyl radical and in which the nitrogen in the 4-position of the piperazine ring forms part of a urea structure bearing a benzylaminoethyl substituent
12/14/1999	US6001830 Heterocyclic compounds
12/14/1999	US6001802 Antiproliferative agents
12/14/1999	US6001623 Polynucleotide sequence coding a human enzymatic polypeptide; for developing treatments and diagnostic assays for disease
12/14/1999	US6001603 Polynucleotide sequence coding for a staphylococcus enzmatic protein; for diagnosis, treatment and prevention of bacterial infections; bactericides
12/14/1999	US6001596 Growth-associated protease inhibitor heavy chain precursor
12/14/1999	US6001581 Cation-based bioassay using human metabotropic glutamate receptors
12/14/1999	US6001389 Compositions containing biologically active silicon
12/14/1999	US6001354 GRB2 associating polypeptides and nucleic acids encoding therefor
12/14/1999	CA2186526C Method and product for regulating cell responsiveness to external signals
12/14/1999	CA2181150C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
12/14/1999	CA2172137C Surface loop structural analogues of fibroblast growth factors
12/14/1999	CA2135642C Tat-derived transport polypeptides
12/14/1999	CA2100258C Acridine derivatives
12/14/1999	CA2014971C Inhibitive agent against activity of alpha-amylase
12/14/1999	CA2010636C Substituted pyrroles
12/12/1999	CA2274638A1 Aromatic heterocyclic biaryl compounds, pharmaceutical and cosmetic compositions made thereof and uses
12/09/1999	WO1999063090A2 Protease inhibitor peptides
12/09/1999	WO1999063080A1 HUMAN HOMOLOGUE OF UNC-53 PROTEIN OF $i(C. ELEGANS)
12/09/1999	WO1999062955A1 Method of designing agonists and antagonists to egf receptor family
12/09/1999	WO1999062939A2 Glycoproteins having lipid mobilising properties and therapeutic applications thereof
12/09/1999	WO1999062929A1 17β-NITRO-11β-ARYLSTEROIDS AND THEIR DERIVATIVES HAVING AGONIST OR ANTAGONIST HORMONAL PROPERTIES
12/09/1999	WO1999062928A1 17β-AMINO AND HYDROXYLAMINO-11β-ARYLSTEROIDS AND THEIR DERIVATIVES HAVING AGONIST OR ANTAGONIST HORMONAL PROPERTIES
12/09/1999	WO1999062914A1 Cyclic boroproline compounds
12/09/1999	WO1999062901A1 Aromatic amine derivatives as pharmaceutical agents
12/09/1999	WO1999062897A1 Hiv integrase inhibitors
12/09/1999	WO1999062893A2 Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds
12/09/1999	WO1999062891A1 Potassium channel inhibitors
12/09/1999	WO1999062890A1 Isothiazole derivatives useful as anticancer agents

1 ... 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 ... 1564